ProtoKinetix, Incorporated (PKTX)

Market Cap	3.15M -5.5%
Revenue (ttm)	n/a
Net Income	-376.17K
EPS	-0.00
Shares Out	409.53M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	219,711
Open	0.0077
Previous Close	0.0077
Day's Range	0.0077 - 0.0077
52-Week Range	0.0040 - 0.0149
Beta	0.52
RSI	54.49
Earnings Date	Mar 27, 2026

About ProtoKinetix

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications comprising targeted health care solutions, as well as AAGPs are used for applications in ophthalmology, dermatology, transplants, and biomanufacturing areas. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incor...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 5
• Stock Exchange: OTCMKTS
• Ticker Symbol: PKTX